111 related articles for article (PubMed ID: 29438058)
1. Assessment of Antibody-Dependent Cellular Cytotoxicity by Flow Cytometry.
Duensing TD; Watson SR
Cold Spring Harb Protoc; 2018 Feb; 2018(2):. PubMed ID: 29438058
[TBL] [Abstract][Full Text] [Related]
2. Complement-Dependent Cytotoxicity Assay.
Duensing TD; Watson SR
Cold Spring Harb Protoc; 2018 Feb; 2018(2):. PubMed ID: 29438057
[TBL] [Abstract][Full Text] [Related]
3. Evaluating Antibody-Dependent Cell-Mediated Cytotoxicity by Flow Cytometry.
van der Haar Àvila I; Marmol P; Cany J; Kiessling R; Pico de Coaña Y
Methods Mol Biol; 2019; 1913():181-194. PubMed ID: 30666607
[TBL] [Abstract][Full Text] [Related]
4. Evaluating Antibody-Dependent Cell-Mediated Cytotoxicity by Chromium Release Assay.
van der Haar Àvila I; Marmol P; Kiessling R; Pico de Coaña Y
Methods Mol Biol; 2019; 1913():167-179. PubMed ID: 30666606
[TBL] [Abstract][Full Text] [Related]
5. Assessment of Apoptosis (Programmed Cell Death) by Flow Cytometry.
Duensing TD; Watson SR
Cold Spring Harb Protoc; 2018 Jan; 2018(1):. PubMed ID: 29295901
[TBL] [Abstract][Full Text] [Related]
6. Comparing high-throughput methods to measure NK cell-mediated antibody dependent cellular cytotoxicity during HIV-infection.
Konstantinus IN; Gamieldien H; Mkhize NN; Kriek JM; Passmore JA
J Immunol Methods; 2016 Jul; 434():46-52. PubMed ID: 27094485
[TBL] [Abstract][Full Text] [Related]
7. An improved method to quantify human NK cell-mediated antibody-dependent cell-mediated cytotoxicity (ADCC) per IgG FcR-positive NK cell without purification of NK cells.
Sung AP; Tang JJ; Guglielmo MJ; Redelman D; Smith-Gagen J; Bateman L; Hudig D
J Immunol Methods; 2018 Jan; 452():63-72. PubMed ID: 29113954
[TBL] [Abstract][Full Text] [Related]
8. An Fc engineering approach that modulates antibody-dependent cytokine release without altering cell-killing functions.
Kinder M; Greenplate AR; Strohl WR; Jordan RE; Brezski RJ
MAbs; 2015; 7(3):494-504. PubMed ID: 25933349
[TBL] [Abstract][Full Text] [Related]
9. Characterization of in vitro antibody-dependent cell-mediated cytotoxicity activity of therapeutic antibodies - impact of effector cells.
Chung S; Lin YL; Reed C; Ng C; Cheng ZJ; Malavasi F; Yang J; Quarmby V; Song A
J Immunol Methods; 2014 May; 407():63-75. PubMed ID: 24704820
[TBL] [Abstract][Full Text] [Related]
10. Agonistic effects of anti-CD2 and anti-CD16 antibodies on human natural killer killing.
Uggla CK; Geisberg M; Jondal M; Knowles RW
Scand J Immunol; 1989 May; 29(5):507-15. PubMed ID: 2567053
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of antibody-dependent cell-mediated cytotoxicity by endowing IgG with FcαRI (CD89) binding.
Borrok MJ; Luheshi NM; Beyaz N; Davies GC; Legg JW; Wu H; Dall'Acqua WF; Tsui P
MAbs; 2015; 7(4):743-51. PubMed ID: 25970007
[TBL] [Abstract][Full Text] [Related]
12. lenalidomide enhances natural killer cell and monocyte-mediated antibody-dependent cellular cytotoxicity of rituximab-treated CD20+ tumor cells.
Wu L; Adams M; Carter T; Chen R; Muller G; Stirling D; Schafer P; Bartlett JB
Clin Cancer Res; 2008 Jul; 14(14):4650-7. PubMed ID: 18628480
[TBL] [Abstract][Full Text] [Related]
13. 51Cr release assay of antibody-dependent cell-mediated cytotoxicity (ADCC).
Nelson DL; Kurman CC; Serbousek DE
Curr Protoc Immunol; 2001 May; Chapter 7():Unit 7.27. PubMed ID: 18432838
[TBL] [Abstract][Full Text] [Related]
14. Target-induced natural killer cell loss as a measure of NK cell responses.
Warren H
Curr Protoc Immunol; 2012 Apr; Chapter 14():Unit 14.29.1-15. PubMed ID: 22470134
[TBL] [Abstract][Full Text] [Related]
15. Flow cytometry-based assessment of direct-targeting anti-cancer antibody immune effector functions.
Miller ML; Finn OJ
Methods Enzymol; 2020; 632():431-456. PubMed ID: 32000909
[TBL] [Abstract][Full Text] [Related]
16. Antibody-dependent cell-mediated cytotoxicity: a flow cytometry-based assay using fluorophores.
Wilkinson RW; Lee-MacAry AE; Davies D; Snary D; Ross EL
J Immunol Methods; 2001 Dec; 258(1-2):183-91. PubMed ID: 11684135
[TBL] [Abstract][Full Text] [Related]
17. Flow cytometry-based cytotoxicity and antibody binding assay.
Alheim M
Curr Protoc Cytom; 2013 Oct; 66():6.34.1-6.34.11. PubMed ID: 24510725
[TBL] [Abstract][Full Text] [Related]
18. Characterization and utilization of a monoclonal antibody inhibiting porcine natural killer cell activity for isolation of natural killer and killer cells.
Dato ME; Kim YB
J Immunol; 1990 Jun; 144(11):4452-62. PubMed ID: 1971298
[TBL] [Abstract][Full Text] [Related]
19. A novel multiparametric flow cytometry-based cytotoxicity assay simultaneously immunophenotypes effector cells: comparisons to a 4 h 51Cr-release assay.
Kim GG; Donnenberg VS; Donnenberg AD; Gooding W; Whiteside TL
J Immunol Methods; 2007 Aug; 325(1-2):51-66. PubMed ID: 17617419
[TBL] [Abstract][Full Text] [Related]
20. Ex vivo-activated human macrophages kill chronic lymphocytic leukemia cells in the presence of rituximab: mechanism of antibody-dependent cellular cytotoxicity and impact of human serum.
Lefebvre ML; Krause SW; Salcedo M; Nardin A
J Immunother; 2006; 29(4):388-97. PubMed ID: 16799334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]